amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis
... TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with 1545[r] ...
48
Amyotrophic lateral sclerosis
... TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with 1460[r] ...
46
Amyotrophic lateral sclerosis
... Abstract Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by progressive muscular paralysis reflecting degeneration of motor neurones in the primary motor cortex, ...
22
Kinesitherapy in amyotrophic lateral sclerosis
... SUMMARY Introduction and purpose of work. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of unknown etiology. As a result, damage to motor neurons in patients with ...
11
Running head: AMYOTROPHIC LATERAL SCLEROSIS 1. Amyotrophic Lateral Sclerosis. Alli Gulley. Radford University
... Amyotrophic lateral sclerosis (ALS) is a type of neuromuscular disease that causes motor neurons to deteriorate (Blasco et al., 2012; Porth, 2011).. ALS is a progressive disease that.[r] ...
21
Controversies and priorities in amyotrophic lateral sclerosis
... Introduction In the autumn of 2011, a monumental discovery changed the way we understand amyotrophic lateral sclerosis (ALS). Some 150 years after Charcot provided the first description of ALS, a ...
31
Sport and risk of amyotrophic lateral sclerosis
... Physical activity and risk of amyotrophic lateral sclerosis Data from the literature on vigorous physical activity as a risk factor for ALS are divergent. Chio et al. [2] studied a cohort of 7325 ...
12
Interneuron dysfunction in amyotrophic lateral sclerosis
... vii SUMMARY Despite more than a century of research, there is still no cure for amyotrophic lateral sclerosis (ALS) and the only available therapeutic extends survival by mere months. The most common ...
157
Rodent models of amyotrophic lateral sclerosis
... Lopez, J. Morré, B. Kalyanaraman, J.S. Beckman, Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice, Neurobiol. Dis. 45 (2012) 137–144. [117] C.P.W. Soon, P.S. Donnelly, ...
16
Neurodegenerative Disease Amyotrophic Lateral Sclerosis
... the neuron-specific expression of bicaudal D2 N-terminus (BICD2-N), a motor-adaptor protein, impairs dynein–dynactin function, causing the appearance of giant NF swellings in the proximal axon. 31 Modification in NF ...
5
What causes amyotrophic lateral sclerosis?
... Figure 1. The time course of amyotrophic lateral sclerosis (ALS). Time is represented along the x-axis; physical health and molecular damage are represented along the y-axis. With time, molecular ...
11
The genetic landscape of amyotrophic lateral sclerosis
... Amyotrophic lateral sclerosis (ALS) is one such disease that could benefit from this technique. As a rapid-onset disease, the time to diagnosis must match this speed if we want to increase our ...
199
Respiratory measures in amyotrophic lateral sclerosis
... for Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, Clinical Neurophysiology-Neurophysiologie Clinique, and Neurology Research International; AG is an inves- tigator for AB Sciences, ...
11
Risk factors for amyotrophic lateral sclerosis
... Email [email protected] Abstract: Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease. It is typically fatal within 2–5 years of symptom onset. The incidence of ALS is largely ...
13
Amyotrophic lateral sclerosis mimic syndromes
... Amyotrophic lateral sclerosis (ALS) is a progressive and almost always devastating neurodegenerative disorder. It is a kind of a heterogeneous group of disorders known as motor neuron diseases ...
7
Genetics of amyotrophic lateral sclerosis: an update
... 112. Brockington A: Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2006, 65:26 – 36. 113. ...
15
Retromer deficiency in amyotrophic lateral sclerosis
... IN AMYOTROPHIC LATERAL SCLEROSIS Eduardo J Pérez-Torres The retromer is a protein complex whose function is to mediate the recycling of proteins from the endosome to either the plasma membrane or the ...
240
Amyotrophic Lateral Sclerosis and Multiple Sclerosis Overlap: A Case Report
... The concurrence of amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) is extremely rare. We reported the case of a 33-year-old woman with a past history of paresthesias at the ...
5
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
... Abstract The last 30 years have seen a major advance in the understanding of the clinical and pathological heterogeneity of amyotrophic lateral sclerosis (ALS), and its overlap with frontotemporal ...
25